Gene Symbol |
Definition |
Felxi PID |
Halo PID |
Nluc-N PID |
Nluc-C PID |
PIP5K1C |
phosphatidylinositol-4-phosphate 5-kinase, type I, gamma, transcript variant 2 |
FXC00103
|
FHC00103
|
FNC00103N
|
FNC00103C
|
TNC |
tenascin C |
FXC00319
|
FHC00319
|
FNC00319N
|
FNC00319C
|
COL4A5 |
collagen, type IV, alpha 5, transcript variant 1
|
FXC00336
|
FHC00336
|
|
|
LAMC1 |
laminin, gamma 1 (formerly LAMB2) |
FXC00341
|
FHC00341
|
FNC00341N
|
FNC00341C
|
VWF |
von Willebrand factor |
FXC00349
|
FHC00349
|
FNC00349N
|
FNC00349C
|
ARHGEF7 |
Rho guanine nucleotide exchange factor (GEF) 7, transcript variant 1 |
FXC00426
|
FHC00426
|
FNC00426N
|
FNC00426C
|
PXDN |
peroxidasin |
FXC00470
|
FHC00470
|
FNC00470N
|
FNC00470C
|
RNMT |
RNA (guanine-7-) methyltransferase, transcript variant 2 |
FXC00528
|
FHC00528
|
FNC00528N
|
FNC00528C
|
PAK4 |
p21 protein (Cdc42/Rac)-activated kinase 4, transcript variant 5 |
FXC00749
|
FHC00749
|
FNC00749N
|
FNC00749C
|
PAK5 |
p21 (RAC1) activated kinase 5 (PAK5), transcript variant 1 |
FXC00788
|
FHC00788
|
FNC00788N
|
FNC00788C
|
ARHGAP35 |
Rho GTPase activating protein 35 |
FXC00901
|
FHC00901
|
FNC00901N
|
FNC00901C
|
ITGA7 |
integrin, alpha 7, transcript variant 2 |
FXC01003
|
FHC01003
|
FNC01003N
|
FNC01003C
|
PAK6 |
p21 protein (Cdc42/Rac)-activated kinase 6, transcript variant 1 |
FXC01015
|
FHC01015
|
FNC01015N
|
FNC01015C
|
ROCK2 |
Rho-associated, coiled-coil containing protein kinase 2 |
FXC01105
|
FHC01105
|
FNC01105N
|
FNC01105C
|
FN1 |
fibronectin 1 |
FXC01189
|
FHC01189
|
FNC01189N
|
FNC01189C
|
LAMA4 |
laminin, alpha 4, transcript variant 1 |
FXC01193
|
FHC01193
|
FNC01193N
|
FNC01193C
|
PIK3CA |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
FXC01204
|
FHC01204
|
FNC01204N
|
FNC01204C
|
MYLK |
myosin light chain kinase, transcript variant 1 |
FXC01214
|
FHC01214
|
FNC01214N
|
FNC01214C
|
ITGB7 |
integrin, beta 7, transcript variant 1 |
FXC01226
|
FHC01226
|
FNC01226N
|
FNC01226C
|
BIRC2 |
baculoviral IAP repeat containing 2, transcript variant 1 |
FXC01241
|
FHC01241
|
FNC01241N
|
FNC01241C
|
LAMB1 |
laminin, beta 1 |
FXC01248
|
FHC01248
|
FNC01248N
|
FNC01248C
|
BCL2 |
B-cell CLL/lymphoma 2, transcript variant alpha |
FXC01250
|
FHC01250
|
FNC01250N
|
FNC01250C
|
HGF |
hepatocyte growth factor (hepapoietin A; scatter factor), transcript variant 5 |
FXC01260
|
FHC01260
|
FNC01260N
|
FNC01260C
|
MAPK9 |
mitogen-activated protein kinase 9, transcript variant JNK2-b2 |
FXC01315
|
FHC01315
|
FNC01315N
|
FNC01315C
|
PIK3CB |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, transcript variant 1 |
FXC01319
|
FHC01319
|
FNC01319N
|
FNC01319C
|
PIK3R3 |
phosphoinositide-3-kinase, regulatory subunit 3 (gamma), transcript variant 1 |
FXC01326
|
FHC01326
|
FNC01326N
|
FNC01326C
|
IGF1 |
insulin-like growth factor 1 (somatomedin C), transcript variant 4 |
FXC01347
|
FHC01347
|
FNC01347N
|
FNC01347C
|
MAPK1 |
mitogen-activated protein kinase 1, transcript variant 1 |
FXC01388
|
FHC01388
|
FNC01388N
|
FNC01388C
|
DIAPH1 |
diaphanous-related formin 1, transcript variant 1 |
FXC01409
|
FHC01409
|
FNC01409N
|
FNC01409C
|
RAF1 |
Raf-1 proto-oncogene, serine/threonine kinase |
FXC01412
|
FHC01412
|
FNC01412N
|
FNC01412C
|
COL1A2 |
collagen, type I, alpha 2 |
FXC01432
|
FHC01432
|
FNC01432N
|
FNC01432C
|
ITGA5 |
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
FXC01471
|
FHC01471
|
FNC01471N
|
FNC01471C
|
GSK3B |
glycogen synthase kinase 3 beta, transcript variant 2 |
FXC01477
|
FHC01477
|
FNC01477N
|
FNC01477C
|
GRB2 |
growth factor receptor-bound protein 2, transcript variant 1 |
FXC01485
|
FHC01485
|
FNC01485N
|
FNC01485C
|
MAPK3 |
mitogen-activated protein kinase 3, transcript variant 1 |
FXC01500
|
FHC01500
|
FNC01500N
|
FNC01500C
|
RHOA |
ras homolog family member A |
FXC01522
|
FHC01522
|
FNC01522N
|
FNC01522C
|
ACTB |
actin, beta |
FXC01523
|
FHC01523
|
FNC01523N
|
FNC01523C
|
NCOA3 |
nuclear receptor coactivator 3, transcript variant 3 |
FXC01529
|
FHC01529
|
FNC01529N
|
FNC01529C
|
JUN |
jun proto-oncogene |
FXC01532
|
FHC01532
|
FNC01532N
|
FNC01532C
|
CCND1 |
cyclin D1 |
FXC01554
|
FHC01554
|
FNC01554N
|
FNC01554C
|
PDGFRB |
platelet-derived growth factor receptor, beta polypeptide |
FXC01574
|
FHC01574
|
FNC01574N
|
FNC01574C
|
IGF1R |
insulin-like growth factor 1 receptor, transcript variant 2 |
FXC01578
|
FHC01578
|
FNC01578N
|
FNC01578C
|
CCND3 |
cyclin D3, transcript variant 2 |
FXC01582
|
FHC01582
|
FNC01582N
|
FNC01582C
|
CCND2 |
cyclin D2 |
FXC01585
|
FHC01585
|
FNC01585N
|
FNC01585C
|
TLN1 |
talin 1 |
FXC01622
|
FHC01622
|
FNC01622N
|
FNC01622C
|
THBS2 |
thrombospondin 2 |
FXC01773
|
FHC01773
|
FNC01773N
|
FNC01773C
|
COL1A1 |
collagen, type I, alpha 1 |
FXC01780
|
FHC01780
|
FNC01780N
|
FNC01780C
|
LAMB3 |
laminin, beta 3, transcript variant 1 |
FXC01782
|
FHC01782
|
FNC01782N
|
FNC01782C
|
CAPN2 |
calpain 2, (m/II) large subunit, transcript variant 1 |
FXC01819
|
FHC01819
|
FNC01819N
|
FNC01819C
|
THBS1 |
thrombospondin 1 |
FXC01829
|
FHC01829
|
FNC01829N
|
FNC01829C
|
VCL |
vinculin, transcript variant 2 |
FXC01835
|
FHC01835
|
FNC01835N
|
FNC01835C
|
COL4A2 |
collagen, type IV, alpha 2 |
FXC01843
|
FHC01843
|
FNC01843N
|
FNC01843C
|
FLT1 |
fms-related tyrosine kinase 1, transcript variant 1 |
FXC01847
|
FHC01847
|
FNC01847N
|
FNC01847C
|
RASGRF1 |
Ras protein-specific guanine nucleotide-releasing factor 1, transcript variant 3 |
FXC01848
|
FHC01848
|
FNC01848N
|
FNC01848C
|
RAPGEF1 |
Rap guanine nucleotide exchange factor (GEF) 1 |
FXC01856
|
FHC01856
|
FNC01856N
|
FNC01856C
|
PIK3R2 |
phosphoinositide-3-kinase, regulatory subunit 2 (beta), transcript variant 1 |
FXC01882
|
FHC01882
|
FNC01882N
|
FNC01882C
|
ITGA2 |
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor), transcript variant 1 |
FXC01888
|
FHC01888
|
FNC01888N
|
FNC01888C
|
PPP1CB |
protein phosphatase 1, catalytic subunit, beta isozyme, transcript variant 1 |
FXC02071
|
FHC02071
|
FNC02071N
|
FNC02071C
|
CXXC1 |
CXXC finger protein 1, transcript variant 2 |
FXC02185
|
FHC02185
|
FNC02185N
|
FNC02185C
|
AKT1 |
v-akt murine thymoma viral oncogene homolog 1, transcript variant 1 |
FXC02215
|
FHC02215
|
FNC02215N
|
FNC02215C
|
IBSP |
integrin-binding sialoprotein |
FXC02312
|
FHC02312
|
FNC02312N
|
FNC02312C
|
PDGFA |
platelet-derived growth factor alpha polypeptide, transcript variant 2 |
FXC02363
|
FHC02363
|
FNC02363N
|
FNC02363C
|
SOS2 |
son of sevenless homolog 2 (Drosophila) |
FXC02373
|
FHC02373
|
FNC02373N
|
FNC02373C
|
SOS1 |
son of sevenless homolog 1 (Drosophila) |
FXC02380
|
FHC02380
|
FNC02380N
|
FNC02380C
|
KCNH4 |
potassium channel, voltage gated eag related subfamily H, member 4 |
FXC02382
|
FHC02382
|
FNC02382N
|
FNC02382C
|
PDPK1 |
3-phosphoinositide dependent protein kinase 1, transcript variant 1 |
FXC02585
|
FHC02585
|
FNC02585N
|
FNC02585C
|
ILK |
integrin-linked kinase, transcript variant 1 |
FXC02645
|
FHC02645
|
FNC02645N
|
FNC02645C
|
BAD |
BCL2-associated agonist of cell death, transcript variant 1 |
FXC02680
|
FHC02680
|
FNC02680N
|
FNC02680C
|
RAC1 |
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1), transcript variant Rac1 |
FXC02699
|
FHC02699
|
FNC02699N
|
FNC02699C
|
AKT3 |
v-akt murine thymoma viral oncogene homolog 3 |
FXC02812
|
FHC02812
|
FNC02812N
|
FNC02812C
|
CRKL |
v-crk avian sarcoma virus CT10 oncogene homolog-like |
FXC02842
|
FHC02842
|
FNC02842N
|
FNC02842C
|
RAC2 |
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
FXC02856
|
FHC02856
|
FNC02856N
|
FNC02856C
|
RAP1B |
RAP1B, member of RAS oncogene family, transcript variant 1 |
FXC02891
|
FHC02891
|
FNC02891N
|
FNC02891C
|
MAPK10 |
mitogen-activated protein kinase 10, transcript variant 3 |
FXC03139
|
FHC03139
|
FNC03139N
|
FNC03139C
|
ITGB1 |
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12), transcript variant 1A |
FXC03293
|
FHC03293
|
FNC03293N
|
FNC03293C
|
FLNA |
filamin A, alpha, transcript variant 1 |
FXC03392
|
FHC03392
|
FNC03392N
|
FNC03392C
|
MAPK8 |
mitogen-activated protein kinase 8, transcript variant JNK1-b2 |
FXC03521
|
FHC03521
|
FNC03521N
|
FNC03521C
|
PRKCA |
protein kinase C, alpha |
FXC03611
|
FHC03611
|
FNC03611N
|
FNC03611C
|
HRAS |
Harvey rat sarcoma viral oncogene homolog, transcript variant 1 |
FXC03635
|
FHC03635
|
FNC03635N
|
FNC03635C
|
PRKCG |
protein kinase C, gamma |
FXC03659
|
FHC03659
|
FNC03659N
|
FNC03659C
|
SHC1 |
SHC (Src homology 2 domain containing) transforming protein 1, transcript variant 3 |
FXC03742
|
FHC03742
|
FNC03742N
|
FNC03742C
|
PKN1 |
protein kinase N1, transcript variant 1 |
FXC03745
|
FHC03745
|
FNC03745N
|
FNC03745C
|
PKN2 |
protein kinase N2 |
FXC03784
|
FHC03784
|
FNC03784N
|
FNC03784C
|
ITGA2B |
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) |
FXC03930
|
FHC03930
|
FNC03930N
|
FNC03930C
|
CAV1 |
caveolin 1, caveolae protein, 22kDa, transcript variant 1 |
FXC04442
|
FHC04442
|
FNC04442N
|
FNC04442C
|
CAV2 |
caveolin 2, transcript variant 1 |
FXC04443
|
FHC04443
|
FNC04443N
|
FNC04443C
|
ITGA4 |
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) |
FXC05544
|
FHC05544
|
FNC05544N
|
FNC05544C
|
ITGAV |
integrin, alpha V, transcript variant 3 |
FXC05547
|
FHC05547
|
FNC05547N
|
FNC05547C
|
VAV2 |
vav 2 guanine nucleotide exchange factor, transcript variant 2 |
FXC05989
|
FHC05989
|
FNC05989N
|
FNC05989C
|
MYL10 |
myosin, light chain 10, regulatory |
FXC06081
|
FHC06081
|
FNC06081N
|
FNC06081C
|
PARVA |
parvin, alpha |
FXC06274
|
FHC06274
|
FNC06274N
|
FNC06274C
|
PARVG |
parvin, gamma, transcript variant 1 |
FXC06276
|
FHC06276
|
FNC06276N
|
FNC06276C
|
PDGFB |
platelet-derived growth factor beta polypeptide, transcript variant 1 |
FXC06311
|
FHC06311
|
FNC06311N
|
FNC06311C
|
PPP1CA |
protein phosphatase 1, catalytic subunit, alpha isozyme, transcript variant 2 |
FXC06454
|
FHC06454
|
FNC06454N
|
FNC06454C
|
RAP1A |
RAP1A, member of RAS oncogene family, transcript variant 2 |
FXC06588
|
FHC06588
|
FNC06588N
|
FNC06588C
|
CTNNB1 |
catenin (cadherin-associated protein), beta 1, 88kDa, transcript variant 1 |
FXC07714
|
FHC07714
|
FNC07714N
|
FNC07714C
|
ACTG1 |
actin gamma 1, transcript variant 2 |
FXC07847
|
FHC07847
|
FNC07847N
|
FNC07847C
|
PGF |
placental growth factor, transcript variant 1 |
FXC07993
|
FHC07993
|
FNC07993N
|
FNC07993C
|
ACTN4 |
actinin, alpha 4 |
FXC08216
|
FHC08216
|
FNC08216N
|
FNC08216C
|
CRK |
v-crk avian sarcoma virus CT10 oncogene homolog, transcript variant II |
FXC08374
|
FHC08374
|
FNC08374N
|
FNC08374C
|
ZYX |
zyxin, transcript variant 1 |
FXC08391
|
FHC08391
|
FNC08391N
|
FNC08391C
|
RAC3 |
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) |
FXC08439
|
FHC08439
|
FNC08439N
|
FNC08439C
|
COL9A3 |
collagen, type IX, alpha 3 |
FXC08573
|
FHC08573
|
FNC08573N
|
FNC08573C
|
IL6 |
interleukin 6 |
FXC08788
|
FHC08788
|
FNC08788N
|
FNC08788C
|
ACTN1 |
actinin, alpha 1, transcript variant 2 |
FXC08813
|
FHC08813
|
FNC08813N
|
FNC08813C
|
TNNC1 |
troponin C type 1 (slow) |
FXC09322
|
FHC09322
|
FNC09322N
|
FNC09322C
|
XIAP |
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase, transcript variant 1 |
FXC09452
|
FHC09452
|
FNC09452N
|
FNC09452C
|
VEGFC |
vascular endothelial growth factor C |
FXC09559
|
FHC09559
|
FNC09559N
|
FNC09559C
|
EGFR |
epidermal growth factor receptor, transcript variant 1 |
FXC09683
|
FHC09683
|
FNC09683N
|
FNC09683C
|
PTEN |
phosphatase and tensin homolog, transcript variant 1 |
FXC09870
|
FHC09870
|
FNC09870N
|
FNC09870C
|
SPP1 |
secreted phosphoprotein 1, transcript variant 2
|
FXC09895
|
FHC09895
|
|
|
VEGFB |
vascular endothelial growth factor B, transcript variant VEGFB-186 |
FXC09942
|
FHC09942
|
FNC09942N
|
FNC09942C
|
MYL2 |
myosin, light chain 2, regulatory, cardiac, slow |
FXC10057
|
FHC10057
|
FNC10057N
|
FNC10057C
|
MYL12A |
myosin, light chain 12A, regulatory, non-sarcomeric, transcript variant 1 |
FXC10070
|
FHC10070
|
FNC10070N
|
FNC10070C
|
SHC3 |
SHC (Src homology 2 domain containing) transforming protein 3 |
FXC10206
|
FHC10206
|
FNC10206N
|
FNC10206C
|
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
FXC10375
|
FHC10375
|
FNC10375N
|
FNC10375C
|
VAV3 |
vav 3 guanine nucleotide exchange factor, transcript variant 1 |
FXC10465
|
FHC10465
|
FNC10465N
|
FNC10465C
|
SPP1 |
secreted phosphoprotein 1, transcript variant 1 |
FXC10466
|
FHC10466
|
FNC10466N
|
FNC10466C
|
PRKCB |
protein kinase C, beta, transcript variant 2 |
FXC10533
|
FHC10533
|
FNC10533N
|
FNC10533C
|
FYN |
FYN proto-oncogene, Src family tyrosine kinase, transcript variant 1 |
FXC10684
|
FHC10684
|
FNC10684N
|
FNC10684C
|
CLSTN1 |
calsyntenin 1, transcript variant 1 |
FXC10700
|
FHC10700
|
FNC10700N
|
FNC10700C
|
ITGB5 |
integrin, beta 5 |
FXC10710
|
FHC10710
|
FNC10710N
|
FNC10710C
|
PDGFB |
platelet-derived growth factor beta polypeptide |
FXC10772
|
FHC10772
|
FNC10772N
|
FNC10772C
|
ITGB3 |
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) |
FXC10787
|
FHC10787
|
FNC10787N
|
FNC10787C
|
LAMA5 |
laminin, alpha 5 |
FXC10797
|
FHC10797
|
FNC10797N
|
FNC10797C
|
PXN |
paxillin, transcript variant 1 |
FXC10852
|
FHC10852
|
FNC10852N
|
FNC10852C
|
PPP1CC |
protein phosphatase 1, catalytic subunit, gamma isozyme, transcript variant 2 |
FXC10941
|
FHC10941
|
FNC10941N
|
FNC10941C
|
COL6A5 |
collagen, type VI, alpha 5 |
FXC10991
|
FHC10991
|
FNC10991N
|
FNC10991C
|
ACTN2 |
actinin, alpha 2, transcript variant 1 |
FXC11021
|
FHC11021
|
FNC11021N
|
FNC11021C
|
MYLK4 |
myosin light chain kinase family, member 4 |
FXC11219
|
FHC11219
|
FNC11219N
|
FNC11219C
|
ELK1 |
ELK1, member of ETS oncogene family, transcript variant 2 |
FXC11409
|
FHC11409
|
FNC11409N
|
FNC11409C
|
MYLK2 |
myosin light chain kinase 2 |
FXC11428
|
FHC11428
|
FNC11428N
|
FNC11428C
|
VTN |
vitronectin |
FXC11472
|
FHC11472
|
FNC11472N
|
FNC11472C
|
CDC42 |
cell division cycle 42, transcript variant 2 |
FXC11496
|
FHC11496
|
FNC11496N
|
FNC11496C
|
BCAR1 |
breast cancer anti-estrogen resistance 1, transcript variant 6 |
FXC11824
|
FHC11824
|
FNC11824N
|
FNC11824C
|
ERBB2 |
erb-b2 receptor tyrosine kinase 2 |
FXC11836
|
FHC11836
|
FNC11836N
|
FNC11836C
|
SRC |
SRC proto-oncogene, non-receptor tyrosine kinase, transcript variant 1 |
FXC11854
|
FHC11854
|
FNC11854N
|
FNC11854C
|
BRAF |
B-Raf proto-oncogene, serine/threonine kinase |
FXC11883
|
FHC11883
|
FNC11883N
|
FNC11883C
|
ITGA8 |
integrin, alpha 8, transcript variant 1 |
FXC11884
|
FHC11884
|
FNC11884N
|
FNC11884C
|
PAK3 |
p21 protein (Cdc42/Rac)-activated kinase 3, transcript variant 2 |
FXC12049
|
FHC12049
|
FNC12049N
|
FNC12049C
|
LAMA2 |
laminin, alpha 2, transcript variant 1 |
FXC12459
|
FHC12459
|
|
|
LAMB2 |
laminin, beta 2 (laminin S) |
FXC12473
|
FHC12473
|
FNC12473N
|
FNC12473C
|
PDGFRA |
platelet derived growth factor receptor alpha |
FXC12575
|
FHC12575
|
FNC12575N
|
FNC12575C
|
MYLK3 |
myosin light chain kinase 3, transcript variant 1 |
FXC12580
|
FHC12580
|
FNC12580N
|
FNC12580C
|
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
FXC12640
|
FHC12640
|
FNC12640N
|
FNC12640C
|
MET |
MET proto-oncogene, receptor tyrosine kinase, transcript variant 2 |
FXC12649
|
FHC12649
|
FNC12649N
|
FNC12649C
|
PTK2 |
protein tyrosine kinase 2, transcript variant 1 |
FXC12651
|
FHC12651
|
FNC12651N
|
FNC12651C
|
VEGFA |
vascular endothelial growth factor A, transcript variant 6 |
FXC13139
|
FHC13139
|
FNC13139N
|
FNC13139C
|
COL9A1 |
collagen, type IX, alpha 1 |
FXC14312
|
FHC14312
|
FNC14312N
|
FNC14312C
|
PAK2 |
p21 protein (Cdc42/Rac)-activated kinase 2 |
FXC16509
|
FHC16509
|
FNC16509N
|
FNC16509C
|
COL9A2 |
collagen, type IX, alpha 2 |
FXC20248
|
FHC20248
|
FNC20248N
|
FNC20248C
|
CAV3 |
caveolin 3, transcript variant 2 |
FXC21414
|
FHC21414
|
FNC21414N
|
FNC21414C
|
KCNH8 |
potassium channel, voltage gated eag related subfamily H, member 8 |
FXC21449
|
FHC21449
|
FNC21449N
|
FNC21449C
|
KDR |
kinase insert domain receptor (a type III receptor tyrosine kinase) |
FXC21921
|
FHC21921
|
FNC21921N
|
FNC21921C
|
PDGFC |
platelet derived growth factor C, transcript variant 1 |
FXC22085
|
FHC22085
|
FNC22085N
|
FNC22085C
|
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha), transcript variant 2 |
FXC22191
|
FHC22191
|
FNC22191N
|
FNC22191C
|
VEGFA |
vascular endothelial growth factor A
|
FXC22633
|
FHC22633
|
|
|
PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, transcript variant 1 |
FXC23046
|
FHC23046
|
|
|
LAMC3 |
laminin, gamma 3 |
FXC23683
|
FHC23683
|
FNC23683N
|
FNC23683C
|
BIRC3 |
baculoviral IAP repeat containing 3, transcript variant 1 |
FXC24427
|
FHC24427
|
FNC24427N
|
FNC24427C
|
RNASE1 |
ribonuclease, RNase A family, 1 (pancreatic), transcript variant 4 |
FXC25083
|
FHC25083
|
FNC25083N
|
FNC25083C
|
SHC4 |
SHC (Src homology 2 domain containing) family, member 4 |
FXC25382
|
FHC25382
|
FNC25382N
|
FNC25382C
|
ITGA3 |
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor), transcript variant a
|
FXC26102
|
FHC26102
|
|
|
ROCK1 |
Rho-associated, coiled-coil containing protein kinase 1 |
FXC26266
|
FHC26266
|
FNC26266N
|
FNC26266C
|
VAV1 |
vav 1 guanine nucleotide exchange factor, transcript variant 1 |
FXC26428
|
FHC26428
|
FNC26428N
|
FNC26428C
|
COMP |
cartilage oligomeric matrix protein |
FXC26548
|
FHC26548
|
FNC26548N
|
FNC26548C
|
AKT2 |
v-akt murine thymoma viral oncogene homolog 2, transcript variant 1 |
FXC26633
|
FHC26633
|
FNC26633N
|
FNC26633C
|
FIGF |
c-fos induced growth factor (vascular endothelial growth factor D) |
FXC27307
|
FHC27307
|
FNC27307N
|
FNC27307C
|
ARHGAP5 |
Rho GTPase activating protein 5, transcript variant 1 |
FXC28245
|
FHC28245
|
FNC28245N
|
FNC28245C
|
LAMA1 |
laminin, alpha 1 |
FXC28523
|
FHC28523
|
FNC28523N
|
FNC28523C
|
VASP |
vasodilator-stimulated phosphoprotein |
FXC28647
|
FHC28647
|
FNC28647N
|
FNC28647C
|
RELN |
reelin, transcript variant 1 |
FXC29259
|
FHC29259
|
FNC29259N
|
FNC29259C
|
FLNC |
filamin C, gamma, transcript variant 1 |
FXC30232
|
FHC30232
|
FNC30232N
|
FNC30232C
|